Viridian Therapeutics Q2 2018 Earnings Report

Total Revenue
$2.18M
Previous year: $718K
+203.9%
EPS
-$0.29
Previous year: -$5.1
-94.3%

Viridian Therapeutics

Viridian Therapeutics